BaltCap’s Medicap exit shortlisted for Emerging Europe Deal of the Year

Every year, The Private Equity Awards hosted by Real Deals recognizes the best of European private equity. The shortlists for the 2014 awards have now been announced and BaltCap’s exit from Medicap has been nominated in the category of Emerging Europe Deal of the Year.


BaltCap originally invested in Medicap in 2008. Together with the management team BaltCap carried out a regional buy-and-build strategy, expanding the company in its home market Estonia, as well as in Finland and Lithuania, in total growing the company’s revenues by more than four times. Medicap was acquired by synlab, a leading European provider of medical laboratory services in July 2013.


Now in their thirteenth year, the awards have become well known and recognized in the private equity industry and among those that advise it. It is the first time that a BaltCap deal has been nominated for The Private Equity Awards.


Winners will be announced on 10 April.


Additional information: